It’s impossible to avoid headlines about GLP-1 medications. The weight-loss drugs target hormones in the gut and brain that affect appetite and feelings of fullness.
For some people with obesity, the medications have been life-changing. For others, the cost of these drugs makes taking them impossible.
Dr. Jorge Moreno, an obesity specialist at Yale Medicine, joins Here & Now to discuss accessibility to GLP-1s.
This article was originally published on WBUR.org.
Copyright 2025 WBUR